InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the full record of transactions filed by Astle Christopher. Director active across 1 company, notably Zymeworks Inc.. Cumulatively, 4 disclosures have been logged. Activity tracked since 12 December 2022. The latest transaction was disclosed on 5 January 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Astle Christopher has 4 filings in total, all within the 4 sampled filings, concerning Zymeworks Inc. (XNAS), where he is SVP & Chief Financial Officer. Over the period from 2022-12-14 to 2024-01-08, the indicated buy and sell amounts are 0, and the most frequent transaction nature is Option exercise.